When caused by a bone marrow disorder, thrombocytosis is called autonomous, primary or essential thrombocytosis or essential thrombocythemia.

Primary thrombocytosis (due to proliferation of megakaryocytes)

essential thrombocytosis (ET), which is also called essential thrombocythemia

The opposite of thrombocytopenia is called thrombocytosis.

Primary thrombocytosis (due to proliferation of megakaryocytes)

Essential Thrombocytosis: It is also known as primary thrombocythemia.

Secondary thrombocytosis (arising on the background of a disease)

Primary thrombocytosis (due to proliferation of megakaryocytes)

Thrombocytosis: A low MPV with a high platelet count suggests reactive thrombocytosis, which is common as inflammation, malignancy, and infection.

Thrombocytosis is an elevated number of platelets.

Essential thrombocytosis (ET) is also called essential thrombocythemia.

The peptide is useful in treating essential thrombocythemia and reactive thrombocytosis.

Persistent thrombocytosis (> 1000 × 109/L), unresponsive to therapy

If you have more than 400 million, the condition is called thrombocytosis.

Thrombocyte count < 100 x 109/l, which cannot be explained by treatment